The UK Commission on Pharmacy Professional Leadership set up by the Chief Pharmaceutical Officers of England, Northern Ireland, Scotland and Wales has published
its recommendations for the 'future of pharmacy professional leadership in the UK' on Monday (6 February).
The Commission is co-chaired by Nigel Clarke, Former Chair of the General Pharmaceutical Council, and Professor Dame Jane Dacre, Professor of Medical Education at
University College London Medical School.
The Commission proposes that closer collaboration between professional leadership bodies and specialist professional groups as part of a Pharmacy Leadership Council
will enable and support pharmacists and pharmacy technicians to meet the opportunities and challenges ahead.
The Council will be set up in 2023 to lead the implementation of the report's vision and recommendations over five years.
Commission Co-Chairs, Professor Dame Jane Dacre and Nigel Clarke: "The Commission has set out a collaborative approach to transform pharmacy professional leadership
and deliver sustained benefits for patients and the public and pharmacy professionals in the UK.
The General Pharmaceutical Council is appointing a new Chief Pharmacy Officer to strengthen the professional voice within the senior leadership team. This
introduction is aimed at fostering a culture of enterprise leadership, inclusion and collaboration within the organisation, GPhC said in a statement.
According to GPhC, the Chief Pharmacy Officer will serve as the authoritative representative of the pharmacy regulator in public, within the pharmacy professions,
and increasingly in multi-disciplinary teams and collaborative regulatory work. "They will act as the executive lead on pharmacy inspection and regulatory insight,
providing professional leadership within the GPhC and collaborating closely with pharmacist and pharmacy technician colleagues across the organisation."
The Chief Pharmacy Officer, reporting to the Chief Executive and Registrar, will hold the highest professional position within the GPhC executive, providing pharmacy
leadership across the organisation, GPhC said.
The Royal Pharmaceutical Society has stated that the UK Commission on Pharmacy Professional Leadership lacks the essential transparency, efficiency, and
diligence needed for success, urging a shift in its approach.
The Commission's operational approach hinders its ability to meet the expectations of both the profession and the public, while prioritising government interests
over their needs and preferences, RPS Chief Executive Paul Bennett (R) and President Claire Anderson have jointly said.
In a blog post on September 7, the RPS leaders asserted that the Commission lacks transparency and is progressing slowly in implementing proposals that were published
seven months ago. "Most pharmacy leaders are growing frustrated and increasingly impatient with the Commission's perceived lack of "meaningful progress" in enhancing
leadership within the field," the pair noted.
In June 2022, the four UK Chief Pharmaceutical Officers (CPhOs) formed an independent Commission with leadership expertise drawn from various domains, both within
and outside of pharmacy, to assess the future of professional leadership. The Pharmacy Minister Neil O'Brien recently revealed that the Commission's costs, funded
by the offices of the CPhOs, amounted to £87,745.
Professional leadership bodies from around the world discussed workforce shortages in community pharmacy and other challenges affecting the sector at a global
meeting held in Paris last month.
Delegated from Denmark, Australia, Ireland, New Zealand, Portugal, Spain, US and the UK updated the conference on how the profession was progressing in practice,
technology and workforce development in their respective countries.
The UK was represented at World Pharmacy Council meeting by National Pharmacy Association chair Andrew Lane and chief executive at the Pharmaceutical Services
Negotiating Committee Janet Morrison.
Lane said: "It's very useful to be part of a global network of pharmacy bodies who are all going through similar challenges as we are in the UK. Sharing intelligence
on other pharmacy systems around the world helps us to prepare the right strategy for engaging with the NHS at home.
"Hearing some of the strides in services and digital technology in the profession gives us hope for the future of the sector. It's clear however that key challenges
such as workforce shortages are starting to have an effect in other parts of the world too."
The Royal Pharmaceutical Society (RPS) has confirmed it will respond to UK Commission's 'call for evidence' on pharmacy professional leadership.
The commission wants to ensure the professions are well equipped, with a voice to help shape the future, and enabled to develop through sharing and learning from
best practice.
The UK Commission on Pharmacy Professional Leadership has been set up by the chief pharmaceutical officers of England, Scotland, Wales and Northern Ireland. It will
produce recommendations for the future of pharmacy professional leadership in the UK.
The commission is co-chaired by Nigel Clarke, former chair of the General Pharmaceutical Council, and Professor Dame Jane Dacre, professor of medical education at
University College London's Medical School.
The commission will be hosting a webinar and has urged the associations and individuals to take part in 'call for evidence' which has been launched to inform and
develop its work.
A webinar in England will take place on Wednesday 7 September 6:30 - 8 pm. In Scotland it will be organised on Tuesday 6 September 7-8:30 pm and in Wales it will be
hosted on Thursday 8 September 7-8:30 pm.
The Pharmacists' Defence Association (PDA) has become a member of the International Pharmaceutical Federation (FIP).
On Thursday (22 September), the FIP council voted to welcome the PDA as a full member of the global federation of organisations that brings together and advances
pharmacy.
Mark Koziol, PDA chairman, said: "Being admitted to FIP with such a decisive level of support from its Council means that the PDA can ensure that UK pharmacists
can enjoy a clear and powerful voice representing their collective professional interests at global level, which of late they could not.
"Bringing one of the largest pharmacy membership organisations in the world to FIP also gives the PDA significant influence in being able to inform the policies of
the World Health Organisation. This means that the PDA can do even more for members by helping to make pharmacy practice more professionally fulfilling for them."
"The PDA constantly seeks ways to provide even better support for members; membership of FIP will give the PDA much more influence and will result in better outcomes
for pharmacists," the association said.
To support humanitarian crises in other parts of the world, the PDA approached FIP, as a global pharmacy leadership organisation.
The Royal Pharmaceutical Society (RPS) has revealed the "differential attainment" gap among Black pharmacy students and Foundation trainees.
Research conducted by pharmacy education has revealed unique challenges leading to lower attainment in the registration assessment and an undergraduate awards
gap compared to white students.
The organisation plans to work with new groups including BPSA, GPhC, NHS England, Pharmacy Schools Council and representatives from Schools of Pharmacy, to achieve
a fair and equitable education and training experience for the students.
They plan to reach out to student representative organisations to secure their participation in a quarterly meeting of the group.
Differential attainment is the unexplained variation between groups who share a protected characteristic, for example, ethnicity, gender and disability.
The General Pharmaceutical Council (GPhC) recently appointed a chief pharmacy officer and a chief enforcement officer on 26 October.
Roz Gittins will be joining as chief pharmacy officer and deputy registrar whereas Dionne Spence as chief enforcement officer and deputy registrar from 3 January.
The regulator confirmed that the new officers will "form the new executive structure of the GPhC".
They will be working with the existing staff members Mark Voce, in his new role, is the chief strategy officer and deputy registrar and Jonathan Bennetts,
will be the chief operating officer & deputy registrar.
It is stated that Gittins is to serve as "the most senior member of the profession," offering pharmacy leadership throughout the GPhC.
The General Pharmaceutical Council (GPhC) will launch a new group focusing on improvement of the post-registration practice of pharmacists and pharmacy technicians.
The announcement follows GPhC and Pharmaceutical Society of Northern Ireland (PSNI) bringing together key stakeholders from across England, Scotland, Wales and
Northern Ireland on Thursday (January 27) to discuss establishment of the group.
The GPhC considered recommendations from a short-life working group chaired by Council member Aamer Safdar on the potential leadership and quality assurance role of the GPhC in post-registration education and training for pharmacists and pharmacy technicians.
Nigel Clarke, chair of the GPhC noted that there is a wide range of activity in the post-registration sphere with government and statutory education providers taking steps to make improvement.
Kamila Hawthorne, the chair of the Royal College of General Practitioners (RCGP) Council, was honoured with the GG2 Woman of the Year Award at the annual
GG2 Leadership and Diversity Awards, held at the Park Plaza Hotel on Tuesday, 5 March.
Hawthorne has been a practitioner and a mentor to young GPs for almost 35 years, and has led pioneering research projects focusing on health inequalities,
diabetes and heart disease. She has been recognised twice as GP of the Year for her work with minority ethnic communities.
Professor Kiran Patel, Group Chief Medical Officer at University Hospitals Birmingham NHS Foundation Trust, was named the GG2 Man of the Year Award.
Apart from being a sought-after cardiologist and consultant, Patel also possesses a wealth of experience in managerial roles. He has done a lot of work in
addressing health inequalities, and notably, in 2020, he prescribed the very first COVID-19 vaccine.